Best Practice & Research Clinical Haematology

Papers
(The H4-Index of Best Practice & Research Clinical Haematology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes61
CAR T and CAR NK cells in multiple myeloma: Expanding the targets38
Monoclonal antibodies in multiple myeloma: Current and emerging targets and mechanisms of action27
Molecular markers in ALL: Clinical implications27
Second malignancies in multiple myeloma; emerging patterns and future directions26
COVID-19 disease and immune dysregulation25
Immunologic effects on the haematopoietic stem cell in marrow failure23
Reconstructing the evolutionary history of multiple myeloma19
The promise of macrophage directed checkpoint inhibitors in myeloid malignancies17
CD33 directed bispecific antibodies in acute myeloid leukemia15
Tracking of low disease burden in multiple myeloma: Using mass spectrometry assays in peripheral blood15
Treatment of telomeropathies15
Immune checkpoint inhibitors in acute myeloid leukemia15
Perspectives on current survival and new developments in AML14
Acute myeloid leukemia and artificial intelligence, algorithms and new scores14
0.020961999893188